FAMOTIDINE OMEGA -(WITHOUT PRESERVATIVE) 10 MG
FAMOTIDINE : 10 MG · DIN 02247735 · OMEGA LABORATORIES LIMITED
Health Canada status: MARKETED
What is FAMOTIDINE OMEGA -(WITHOUT PRESERVATIVE)?
FAMOTIDINE OMEGA -(WITHOUT PRESERVATIVE) 10 MG contains FAMOTIDINE : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 02247735, held by OMEGA LABORATORIES LIMITED, supplied as SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 30-Oct-2003. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is FAMOTIDINE OMEGA -(WITHOUT PRESERVATIVE) used for?
Famotidine is indicated in the treatment of the following conditions where a controlled reduction of gastric secretion is required: 1. Treatment of acute duodenal ulcer; 2. Prophylactic use in duodenal ulcer; 3. Treatment of acute benign gastric ulcer; 4. Treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison Syndrome); 5. Treatment of gastroesophageal reflux disease (GERD); 6. Maintenance of remission of patients with GERD. Famotidine injection is indicated in some hospitalized patients with pathological hypersecretory conditions or intractable ulcers, or as an alternative to the oral dosage form for short-term use in patients who are unable to take oral medication.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02247735 |
|---|---|
| Brand name | FAMOTIDINE OMEGA -(WITHOUT PRESERVATIVE) |
| Generic / active ingredient | FAMOTIDINE : 10 MG |
| Manufacturer | OMEGA LABORATORIES LIMITED |
| Strength | 10 MG |
| Dosage form | SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Prescription |
| ATC code | A02BA03 FAMOTIDINE |
| AHFS class | 56:28.12 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 30-Oct-2003 |
| Original market date | 2003-10-30 00:00:00 |
How is it stored and handled?
Store between 2 and 8°C. Protect from light. Do not freeze.
How is it supplied?
10 x 2 mL vials, 4 mL vials, 20 mL vials
Is FAMOTIDINE in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by OMEGA LABORATORIES LIMITED (Tier 3 shortage FAMOTIDINE OMEGA -(WITHOUT PRESERVATIVE)" aria-label="Actual Tier 3 shortage FAMOTIDINE OMEGA -(WITHOUT), last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
Check availability for FAMOTIDINE OMEGA -(WITHOUT PRESERVATIVE)
What can be used instead?
Other Canadian products sharing ATC code A02BA03 FAMOTIDINE. 17 of 68 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACID CONTROLLER MAXIMUM STRENGTH | 20 MG | TABLET | ANGITA PHARMA INC. | MARKETED | DIN 02538350 |
| AG-FAMOTIDINE | 20 MG | TABLET | ANGITA PHARMA INC. | MARKETED | DIN 02509970 |
| AG-FAMOTIDINE | 40 MG | TABLET | ANGITA PHARMA INC. | MARKETED | DIN 02509989 |
| FAMOTIDINE | 20 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02549107 |
| FAMOTIDINE | 20 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02351102 |
| FAMOTIDINE | 40 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02549115 |
| FAMOTIDINE | 40 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02351110 |
| FAMOTIDINE OMEGA -(WITH PRESERVATIVE,BENZYL ALCOHOL) | 10 MG | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02247745 |
| JAMP FAMOTIDINE | 20 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02507749 |
| JAMP FAMOTIDINE | 40 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02507757 |
Who else supplies FAMOTIDINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. FAMOTIDINE appears in 69 registered pack listings across 8 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Request a quote for FAMOTIDINE OMEGA -(WITHOUT PRESERVATIVE)
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.